Carcinoma In Situ Breast cancer

Breast Conservation Therapy May Be Better than a Mastectomy (09-17-2014)

Breast cancer claims the lives of approximately 40,000 women annually in the United States alone. Early-stage breast cancer refers to cancer that has not spread from its site of origin. Patients with early-stage breast cancer have a high cure rate with... Continue Reading

Risk of Breast Cancer Recurrence Doesn’t Increase with TNF Inhibitor Use (08-28-2014)

According to the results of a recently published study from Swedish investigators treatment with tumor necrosis factor inhibitors (TNF) does not appear to increase the rate of breast cancer recurrence among patients with rheumatoid arthritis (RA).  The... Continue Reading

Recent Study Finds That African American Women Less Likely To Receive Standard Breast Cancer Treatment (07-7-2014)

New research from the The University of Texas MD Anderson Cancer Center found that African American women diagnosed with early stage invasive breast cancer were 12 percent less likely than Caucasian women with the same diagnosis to receive axillary sentinel... Continue Reading

Zoladex Shows Fertility Advantages in Treatment of Early Breast Cancer (06-30-2014)

At the 2014 American Society of Clinical Oncology® meeting in Chicago, researchers reported that women with early stage hormone receptor-negative (HR-negative) breast cancer who were treated with Zoladex® (goserelin) had a reduced rate of ovarian failure... Continue Reading

Ask the Expert: Making Informed Decisions about Breast Reconstruction (06-18-2014)

July 16, 2014 at 6:30pm EST CancerConnect live Web Chat with an Expert series presents:  “Making Informed Decisions about Breast Reconstruction.”  On July 16, 2014 at 6:30pm EST you will have the opportunity to engage with a breast cancer expert... Continue Reading

Tykerb and Herceptin Combination Therapy Fails to Improve Outcomes for Early Stage HER2 Breast Cancer (06-10-2014)

Dr. Martine Piccart-Gebhart presented results at the 2014 annual meeting of the American Society of Clinical Oncology showing that a combination treatment of Tykerb® (lapatinib) and Herceptin® (trastuzumab) offered no benefit in outcomes for early stage... Continue Reading

Updated Guidelines for Adjuvant Tamoxifen in Hormone-Positive Breast Cancer (05-29-2014)

The American Society of Clinical Oncology (ASCO) has updated their guidelines for the use of adjuvant endocrine therapy, particularly adjuvant tamoxifen (Nolvadex®), for women with hormone receptor-positive breast cancer. This update, which focuses on... Continue Reading

Ask the Expert: Breast Cancer, Diet and Exercise (05-19-2014)

CancerConnect recently partnered with Dana-Farber to provide you with the opportunity to engage with a breast cancer expert, Jennifer A. Ligibel, MD, of the Susan F. Smith Center for Women’s Cancers at Dana-Farber. On May 7 and 8, 2014, Dr. Ligibel... Continue Reading

Updated Guidelines for Sentinel Node Biopsy in Early Stage Breast Cancer (04-2-2014)

The American Society of Clinical Oncology (ASCO) has issued new recommendations for the use of sentinel lymph node biopsy in patients with early stage breast cancer. The guidelines were published online in the Journal of Clinical Oncology. For women... Continue Reading

Fertility Concerns Affect Treatment Decisions in Younger Women with Breast Cancer (03-26-2014)

Fertility concerns affect treatment decisions in a substantial proportion of young women with breast cancer; however, few women pursue available fertility preservation strategies, according to the results of a study published in the Journal of Clinical... Continue Reading

« Previous PageNext Page »